Transcytosis is used alone (e.g., hepatoma HepG2 cells) or in combination with a direct pathway from the Golgi (e.g., epithelial MDCK cells) as an indirect route for targeting proteins to the apical surface. The raft-associated MAL protein is an essential element of the machinery for the direct route in MDCK cells. Herein, we present the functional characterization of MAL2, a member of the MAL protein family, in polarized HepG2 cells. MAL2 resided selectively in rafts and is predominantly distributed in a compartment localized beneath the subapical F-actin cytoskeleton. MAL2 greatly colocalized in subapical endosome structures with transcytosing molecules en route to the apical surface. Depletion of endogenous MAL2 drastically blocked transcytotic transport of exogenous polymeric immunoglobulin receptor and endogenous glycosylphosphatidylinositol-anchored protein CD59 to the apical membrane. MAL2 depletion did not affect the internalization of these molecules but produced their accumulation in perinuclear endosome elements that were accessible to transferrin. Normal transcytosis persisted in cells that expressed exogenous MAL2 designed to resist the depletion treatment. MAL2 is therefore essential for transcytosis in HepG2 cells.
Skip Nav Destination
Article navigation
14 October 2002
Report|
October 07 2002
MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells
María C. de Marco,
María C. de Marco
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Search for other works by this author on:
Fernando Martín-Belmonte,
Fernando Martín-Belmonte
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Search for other works by this author on:
Leonor Kremer,
Leonor Kremer
2Departamento de Immunología and Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Search for other works by this author on:
Juan P. Albar,
Juan P. Albar
2Departamento de Immunología and Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Search for other works by this author on:
Isabel Correas,
Isabel Correas
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Search for other works by this author on:
Jean P. Vaerman,
Jean P. Vaerman
3Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, B-1200 Brussels, Belgium
Search for other works by this author on:
Mónica Marazuela,
Mónica Marazuela
4Departamento de Endocrinología, Hospital de la Princesa, 28006 Madrid, Spain
Search for other works by this author on:
Jennifer A. Byrne,
Jennifer A. Byrne
5Oncology Research Unit and the University of Sidney Department of Pediatrics and Child's Health, The Children's Hospital, Westmead, NSW, 2145, Australia
Search for other works by this author on:
Miguel A. Alonso
Miguel A. Alonso
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Search for other works by this author on:
María C. de Marco
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Fernando Martín-Belmonte
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Leonor Kremer
2Departamento de Immunología and Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Juan P. Albar
2Departamento de Immunología and Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Isabel Correas
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Jean P. Vaerman
3Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, B-1200 Brussels, Belgium
Mónica Marazuela
4Departamento de Endocrinología, Hospital de la Princesa, 28006 Madrid, Spain
Jennifer A. Byrne
5Oncology Research Unit and the University of Sidney Department of Pediatrics and Child's Health, The Children's Hospital, Westmead, NSW, 2145, Australia
Miguel A. Alonso
1Centro de Biología Molecular “Severo Ochoa”, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid and Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049 Madrid, Spain
Address correspondence to Miguel A. Alonso, Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain. Tel.: 34-91-397-8037. Fax: 34-91-397-8087. E-mail: [email protected]
*
Abbreviations used in this paper: GPI, glycosylphosphatidylinositol; pIgR, polymeric immunoglobulin receptor; Tf, transferrin; TfR, Tf receptor.
Received:
June 06 2002
Revision Received:
September 03 2002
Accepted:
September 05 2002
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2002
J Cell Biol (2002) 159 (1): 37–44.
Article history
Received:
June 06 2002
Revision Received:
September 03 2002
Accepted:
September 05 2002
Citation
María C. de Marco, Fernando Martín-Belmonte, Leonor Kremer, Juan P. Albar, Isabel Correas, Jean P. Vaerman, Mónica Marazuela, Jennifer A. Byrne, Miguel A. Alonso; MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells . J Cell Biol 14 October 2002; 159 (1): 37–44. doi: https://doi.org/10.1083/jcb.200206033
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement